Uliana, Daniela L.; Lisboa, João Roberto Fernandes; Gomes, Felipe Villela 
; Grace, Anthony A.
Source: Biochemical Pharmacology. Unidade: FMRP
Subjects: NEURÔNIOS, FÁRMACOS, FARMACOLOGIA, NEUROTRANSMISSORES, NEURÔNIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ULIANA, Daniela L. et al. The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophrenia. Biochemical Pharmacology, v. 228, p. 1-13, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.bcp.2024.116298. Acesso em: 23 jan. 2026.APA
Uliana, D. L., Lisboa, J. R. F., Gomes, F. V., & Grace, A. A. (2024). The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophrenia. Biochemical Pharmacology, 228, 1-13. doi:10.1016/j.bcp.2024.116298NLM
Uliana DL, Lisboa JRF, Gomes FV, Grace AA. The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophrenia [Internet]. Biochemical Pharmacology. 2024 ; 228 1-13.[citado 2026 jan. 23 ] Available from: https://doi.org/10.1016/j.bcp.2024.116298Vancouver
Uliana DL, Lisboa JRF, Gomes FV, Grace AA. The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophrenia [Internet]. Biochemical Pharmacology. 2024 ; 228 1-13.[citado 2026 jan. 23 ] Available from: https://doi.org/10.1016/j.bcp.2024.116298
